GlycoMimetics (NASDAQ:CBIO) Now Covered by Analysts at Lifesci Capital
Lifesci Capital began coverage on shares of GlycoMimetics (NASDAQ:CBIO – Free Report) in a report released on Wednesday morning,Benzinga reports. The firm issued an outperform rating and a $22.00 target price on the biopharmaceutical company’s stock. GlycoMimetics Price Performance Shares of NASDAQ CBIO opened at $14.62 on Wednesday. GlycoMimetics has a one year low of […]
Lifesci Capital began coverage on shares of GlycoMimetics (NASDAQ:CBIO – Free Report) in a report released on Wednesday morning,Benzinga reports. The firm issued an outperform rating and a $22.00 target price on the biopharmaceutical company’s stock. GlycoMimetics Price Performance Shares of NASDAQ CBIO opened at $14.62 on Wednesday. GlycoMimetics has a one year low of […]
